Honghui Zhou

Honghui Zhou

Johnson & Johnson Co. - New Jersey / United States
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 4396681
-
person_outline Honghui Zhou's MOST POPULAR ARTICLES
1-) Association between serum concentration of infliximab and efficacy in adult patients with ulcerative colitisOJ Adedokun, WJ Sandborn, BG Feagan, P Rutgeerts, Z Xu, CW Marano, ...Gastroenterology 147 (6), 1296-1307. e5, 20143152014
2-) Population pharmacokinetic analysis of infliximab in patients with ulcerative colitisAA Fasanmade, OJ Adedokun, J Ford, D Hernandez, J Johanns, C Hu, ...European journal of clinical pharmacology 65 (12), 1211-1228, 20093092009
3-) Pharmacokinetic properties of infliximab in children and adults with Crohn\\\'s disease: a retrospective analysis of data from 2 phase III clinical trialsAA Fasanmade, OJ Adedokun, M Blank, H Zhou, HM DavisClinical therapeutics 33 (7), 946-964, 20112822011
4-) Characterization of golimumab, a human monoclonal antibody specific for human tumor necrosis factor αDJ Shealy, A Cai, K Staquet, A Baker, ER Lacy, L Johns, O Vafa, G Gunn, ...MAbs 2 (4), 428-439, 20103022010
5-) Pharmacokinetics and safety of golimumab, a fully human anti‐TNF‐α monoclonal antibody, in subjects with rheumatoid arthritisH Zhou, H Jang, RM Fleischmann, E Bouman‐Thio, Z Xu, JC Marini, ...The Journal of Clinical Pharmacology 47 (3), 383-396, 20072332007